Sprintec and Motrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sprintec (ethinyl estradiol; norgestimate) and Motrin (ibuprofen). Common drug interactions include cholelithiasis among females.

The phase IV clinical study analyzes what interactions people have when they take Sprintec and Motrin. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Sprintec?

Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.

What is Motrin?

Motrin has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 38,332 Motrin users. Check the latest studies of Motrin.



On Aug, 09, 2026

53 people who take Sprintec and Motrin together, and have interactions are studied.

Sprintec and Motrin drug interactions.

What are the common drug interactions of Sprintec and Motrin, by gender? *:

female:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Abdominal pain
  3. Abdominal distension
  4. Dysmenorrhoea (painful menstruation)
  5. Lymphocyte count decreased
  6. Uterine haemorrhage (uterine bleeding)
  7. Abdominal pain lower
  8. Dyspnoea (difficult or laboured respiration)
  9. Nausea (feeling of having an urge to vomit)
  10. Sinusitis (inflammation of sinus)

male:

n/a

What are the common drug interactions of Sprintec and Motrin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Biliary colic
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Abdominal pain lower
  5. Back pain
  6. Dyspnoea (difficult or laboured respiration)
  7. Escherichia infection (bacterial infection by escherichia coli)
  8. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  9. Heart rate increased
  10. Hypertension (high blood pressure)

20-29:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Gallbladder disorder
  3. Injury
  4. Cholecystitis chronic (long lasting infection of gallbladder)
  5. Vomiting
  6. Abdominal pain
  7. Abdominal pain upper
  8. Dyspnoea (difficult or laboured respiration)
  9. Nausea (feeling of having an urge to vomit)
  10. Abdominal pain lower

30-39:

  1. Migraine (headache)
  2. Dizziness
  3. Sinusitis (inflammation of sinus)
  4. Abdominal pain
  5. Abdominal pain lower
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Blood alkaline phosphatase increased
  9. Blood bilirubin increased
  10. Breast cancer

40-49:

  1. Abdominal pain
  2. Abdominal distension
  3. Feeling of body temperature change
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Neuralgia (pain in one or more nerves)
  6. Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Pancreatitis (inflammation of pancreas)
  9. Device dislocation
  10. Dysmenorrhoea (painful menstruation)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 11.32%
  2. Immunodeficiency Common Variable: 6 people, 11.32%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 9.43%
  4. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 4 people, 7.55%
  5. Depression: 4 people, 7.55%
  6. Premenstrual Syndrome: 3 people, 5.66%
  7. Migraine Without Aura (headache without neurological problems): 3 people, 5.66%
  8. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 5.66%
  9. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 5.66%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Sprintec and Motrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sprintec and Motrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Motrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sprintec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Motrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate and ibuprofen (the active ingredients of Sprintec and Motrin, respectively), and Sprintec and Motrin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: